Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial ...

Studies on caffeine’s effects on heart health have gained interest in recent years. One crucial question remains: How much ...

Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima: Shardul Nautiyal, Mumbai Friday, October 18, 2024, 18:15 Hrs [IST] The Division Bench of the D ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate tablets USP, 0.1 mg.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg (USRLD: Florinef Tablets, 0.1 mg).

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Granules India Limited has recently announced the appointment of Ramraj Rangarajulu as President and Head of Formulations ...

The list of stocks includes fundamental, technical, short-term, long-term, cash, futures and options (F&O), and other segment ...

Macquarie rates Bajaj Auto as neutral citing disappointing gross margins, while Jefferies is optimistic on KEI Industries, ...

Shares of several companies including RIL, Bajaj Auto, L&T Tech, KEI Industries, and LIC Housing Finance, among others, will ...